Damages Back In Play In Pfizer Patent Suit

Law360, New York (September 26, 2007, 12:00 AM EDT) -- A federal judge has reconsidered his ruling in a patent infringement dispute over Pfizer Inc.'s Accupril, deciding to put some potential damages against defendants Ranbaxy Laboratories Ltd. and Teva Pharmaceuticals USA Inc. back on the table.

Judge Dickinson R. Debevoise on Tuesday vacated his April decision, reneging on his former approval of a defendants' motion for summary judgment. The ruling had limited the amount of damages that Pfizer could get from Ranbaxy or Teva.

Judge Debevoise ruled that the issue should be left up to a...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.